Takeda releases internal probe over bad ad

Share this article:

Japanese drugmaker Takeda has released the results of an internal probe over an inappropriate ad for blood pressure medicine BIopress, which, according to the Wall Street Journal, utilized an incorrect chart and “raised suggestions of manipulated trial data.” The company denies wrongdoing. The report is only available in Japanese, however, and WSJ reports that questions regarding an English version have gone unanswered, raising questions on whether the company is trying to be transparent, or merely to appear transparent.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.